Menaquinone-7 (Vitamin K2-7) (Synonyms: MK-7, Vitamin K2(35), Vitamin MK-7) |
| Catalog No.GC32498 |
La menaquinona-7 (vitamina K2-7) (vitamina K2-7), pertenece a una clase de homÓlogos de la vitamina K2, se descubriÓ originalmente como factor antihemorrÁgico.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2124-57-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Menaquinone-7 (Vitamin K2-7), a highly valuable member of the vitamin K series, has significant effects on preventing osteoporosis and cardiovascular disease besides its positive effects on blood coagulation [1].
Menaquinone-7 (10 µM) treated MC3T3E1 cells for 24, 48, 96 and 240 h, no statistical differences at 24, 48 and 96 h, the growth of MK-7 treated cells was significantly suppressed at 240 h. Menaquinone-7 increased osteocalcin, osteoprotegerin, and RANKL mRNA expression in osteoblastic MC3T3E cells [2]. After 24 h of Menaquinone-7 administration, genes upregulated by Menaquinone-7 included tenascin C and BMP2. Genes downregulated by Menaquinone-7 administration included biglycan and butyrophilin [3]. Menaquinone-7 (1 µM) increases alkaline phosphatase activity and calcium content in femoral-metaphyseal tissues isolated from normal and skeletal-unloaded rats [4]. Menaquinone-7 (10 µM) promotes osteoblast maturation thereby increasing osteogenic differentiation [5].
Menaquinone-7 increased The bone formation marker osteocalcin (OC), which is the bone formation marker [6]. Menaquinone-7 (200 mg/1,000 g fed with diets) supplementation decreases the bone resorption index and increases the bone formation index, balancing bone metabolism, and is considered to prevent bone loss [6].
References:
[1]. Mahdinia E, Demirci A, Berenjian A. Production and application of menaquinone-7 (vitamin K2): a new perspective[J]. World Journal of Microbiology and Biotechnology, 2017, 33(1): 1-7.
[2]. Katsuyama H, Otsuki T, Tomita M, et al. Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells[J]. International journal of molecular medicine, 2005, 15(2): 231-236.
[3]. Katsuyama H, Saijoh K, Otsuki T, et al. Menaquinone-7 regulates gene expression in osteoblastic MC3T3E1 cells[J]. International journal of molecular medicine, 2007, 19(2): 279-284.
[4]. Ehara Y, Takahashi H, Hanahisa Y, et al. Effect of vitamin K2 (menaquinone-7) on bone metabolism in the femoral-metaphyseal tissues of normal and skeletal-unloaded rats: enhancement with zinc[J]. Research in experimental medicine, 1996, 196(1): 171-178.
[5]. Akbulut A C, Wasilewski G B, Rapp N, et al. Menaquinone-7 supplementation improves osteogenesis in pluripotent stem cell derived mesenchymal stem cells[J]. Frontiers in cell and developmental biology, 2021, 8: 618760.
[6]. Brown J P, Malaval L, Chapuy M C, et al. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis[J]. The Lancet, 1984, 323(8386): 1091-1093.
Average Rating: 5 (Based on Reviews and 33 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *